These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11553996)

  • 1. Striatal molecular mechanisms and motor dysfunction in Parkinson's disease.
    Chase TN; Konitsiotis S; Oh JD
    Adv Neurol; 2001; 86():355-60. PubMed ID: 11553996
    [No Abstract]   [Full Text] [Related]  

  • 2. Three types of akinesia in the progressive course of Parkinson's disease.
    Narabayashi H
    Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine-acetylcholine-glutamate interactions in the striatum. A working hypothesis.
    Di Chiara G; Morelli M
    Adv Neurol; 1993; 60():102-6. PubMed ID: 8093571
    [No Abstract]   [Full Text] [Related]  

  • 4. "Ottorino Rossi" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology.
    Greenamyre JT
    Funct Neurol; 2000; 15(2):67-80. PubMed ID: 10916718
    [No Abstract]   [Full Text] [Related]  

  • 5. Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications.
    Chase TN; Oh JD
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S122-9; discussion S129-30. PubMed ID: 10762139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease.
    Chase TN; Engber TM; Mouradian MM
    Adv Neurol; 1996; 69():497-501. PubMed ID: 8615171
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction between estradiol, prolactin, and striatal dopaminergic mechanisms.
    Bédard P; Boucher R; Di Paolo T; Labrie F
    Adv Neurol; 1984; 40():489-95. PubMed ID: 6695626
    [No Abstract]   [Full Text] [Related]  

  • 8. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
    Hornykiewicz O
    Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction.
    Costa RM; Lin SC; Sotnikova TD; Cyr M; Gainetdinov RR; Caron MG; Nicolelis MA
    Neuron; 2006 Oct; 52(2):359-69. PubMed ID: 17046697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No relevance to Parkinson's.
    Hefti F; Denton TL; Beck KD; Michel PP
    Nature; 1991 Aug; 352(6336):573. PubMed ID: 1830925
    [No Abstract]   [Full Text] [Related]  

  • 11. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R; Sindhu KM; Chandra G; Mohanakumar KP
    Behav Brain Res; 2005 Sep; 163(2):159-67. PubMed ID: 15941598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical aspects of Parkinson's disease.
    Nagatsu T
    Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
    [No Abstract]   [Full Text] [Related]  

  • 13. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry.
    Owen AM
    Neuroscientist; 2004 Dec; 10(6):525-37. PubMed ID: 15534038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcortical regulatory motor system in the development and its disorders.
    Lesný I
    Acta Univ Carol Med Monogr; 1980; 96():1-74. PubMed ID: 7348097
    [No Abstract]   [Full Text] [Related]  

  • 15. What has been learnt from study of dopamine receptors in Parkinson's disease?
    Hurley MJ; Jenner P
    Pharmacol Ther; 2006 Sep; 111(3):715-28. PubMed ID: 16458973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
    Hornykiewicz O
    Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
    Hodaie M; Neimat JS; Lozano AM
    Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of motor disorders in Parkinson's disease].
    Yanagisawa N
    No To Shinkei; 1989 Jul; 41(7):647-58. PubMed ID: 2684249
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys.
    Cass WA; Grondin R; Andersen AH; Zhang Z; Hardy PA; Hussey-Andersen LK; Rayens WS; Gerhardt GA; Gash DM
    Neurobiol Aging; 2007 Feb; 28(2):258-71. PubMed ID: 16442671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Movement disorders and basal ganglia function].
    Dietrichs E
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.